Leverage Analysis Stories

Investors considering a position in Cal-Maine Foods (NASDAQ: CALM) should note the company's relatively low debt levels, which provide a strong foundation for future growth. With total liabilities of only 344.9 million, the company's balance sheet appears healthy, especially when compared to its net invested capital of 1.6 billion. This low debt level gives Cal-Maine Foods significant financial flexibility, allowing it to invest in growth opportunities or weather potential downturns.
  over six months ago at Macroaxis 
By Aina Ster
Aina Ster
Herbalife Nutrition, a prominent player in the Personal Care Products industry, has shown some intriguing financial dynamics as we head into October. Despite a significant Retained Earnings loss of 1.2B, the company's Total Revenue stands strong at 5.2B, outpacing the Cost Of Revenue of 1.2B. The company's End Period Cash Flow is also robust at 516.3M, supporting a healthy Free Cash Flow of 196.1M.
  over six months ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Independent Bank, a regional bank listed on NASDAQ (USA Stocks: IBCP), has been a subject of discussion among investors due to its potential increase in debt. With net borrowings currently standing at $56M, there is a growing concern about the bank's leverage. However, it's important to note that the bank has a substantial amount of cash and short-term investments, amounting to approximately $853.7M, which could provide a buffer against any potential financial strain.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
As we step into October, investors are keenly observing the potential of Healthcare Triangle, a prominent player in the Healthcare sector listed on NASDAQ. Despite the company's recent financial struggles, with a net loss of 9.6M and an operating income loss of 10.4M, there are several indicators that suggest a possible upside for the stock. The company's total stockholder equity stands at 12.4M, and it has total assets worth 20.8M, demonstrating a solid financial base.
  over six months ago at Macroaxis 
By Nico Santiago
Nico Santiago
Charles Schwab Corp currently has $37.88 billion in liabilities, with a Debt to Equity (D/E) ratio of 0.71. This ratio is roughly average when compared to similar companies. The asset utilization indicator is a measure of the revenue generated for every dollar of assets reported by a company.
  over six months ago at Macroaxis 
By Aina Ster
Aina Ster
TopBuild Corp carries a debt of $1.68 billion, with a debt-to-equity (D/E) ratio of 0.96. This is considered acceptable within its current industry classification. The company has a performance score of 11 on a scale of 0 to 100.
  over six months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Rekor Systems, a domestic technology company specializing in software, recently experienced a 6% pullback, presenting a potential buying opportunity for investors. Despite reporting a loss of $50.9M in EBIT and $43.8M in free cash flow, the company has a total stockholder equity of $49.3M and an end period cash flow of $2.5M. With a total revenue of $19.9M against a cost of revenue of $10.9M, and net receivables of $3.6M, the company's financials show potential for growth.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Asana Inc, a notable player in the Technology sector and specifically in the Software service category, has shown significant financial movements in the recent period. The company's end period cash flow increased significantly to 526.6M from a beginning cash flow of 240.4M, indicating a strong cash management strategy. However, Asana Inc reported a substantial loss in EBIT and net income, both standing at 407.8M.
  over six months ago at Macroaxis 
By Aina Ster
Aina Ster
Investors considering National Bank (CA:NA) should take note of its robust financial health, as evidenced by its significant other cashflows from financing activities, which stands at a substantial 1.2 billion. The bank's total revenue is also noteworthy, reaching 9.6 billion, far surpassing its selling general administrative expense of 3.3 billion. This financial strength is further underscored by the bank's net income applicable to common shares, which is reported at 3.3 billion.
  over six months ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Investing in Akebia Therapeutics (NASDAQ: AKBA) stock presents a mixed bag of opportunities and risks. On the positive side, the company has a Potential Upside of 17.24, suggesting that the stock has room for growth. The Jensen Alpha of 0.432 also indicates a potential for higher returns when adjusted for risk.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson